Page last updated: 2024-12-08

2-tetradecenoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

trans-2-tetradecenoic acid : A 2-tetradecenoic acid having trans-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

tetradecenoic acid : Any C14 straight-chain monounsaturated fatty acid having one C=C double bond. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

2-tetradecenoic acid : A tetradecenoic acid having its double bond in the 2-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5282738
CHEMBL ID4277587
CHEBI ID37271
CHEBI ID61366
SCHEMBL ID1359533
MeSH IDM0124686

Synonyms (37)

Synonym
trans-2-tetradecenoic acid
trans-tetradec-2-enoic acid
trans-2-tetradecensaeure
CHEBI:37271
14:1, n-12 trans
c14:1, n-12 trans
(2e)-tetradec-2-enoic acid
acide trans-2-tetradecenoique
(e)-2-tetradecenoic acid
acido trans-2-tetradecenoico
(e)-tetradec-2-enoic acid
1-tridecenylcarboxylic acid
2-tetradecenoic acid
LMFA01030047
c14:1n-12
tetradec-2-enoic acid
tetradec-2-ensaeure
39525-69-4
14:1, n-12
omega12-myristoleic acid
acido 2-tetradecanoico
c14:1, n-12
CHEBI:61366
2-tetradecensaeure
acide 2-tetradecenoique
AKOS003238540
tetradecenoic acid
26444-03-1
einecs 254-492-9
SCHEMBL1359533
trans-tetra-dec-2-enoic acid
IBYFOBGPNPINBU-OUKQBFOZSA-N
Q27131059
Q27117091
AMY37908
CHEMBL4277587
tetradec-2-enoicacid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
2-tetradecenoic acidA tetradecenoic acid having its double bond in the 2-position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Fatty Acid Biosynthesis233

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1417295Inhibition of electric eel AChE at 10 M using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured at 1 min intervals for 30 mins by Ellman's method2018Bioorganic & medicinal chemistry letters, 11-01, Volume: 28, Issue:20
Unexpected AChE inhibitory activity of (2E)α,β-unsaturated fatty acids.
AID1417297Inhibition of equine serum BuChE at 10 M using butyrylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured at 1 min intervals for 30 mins by Ellman's method2018Bioorganic & medicinal chemistry letters, 11-01, Volume: 28, Issue:20
Unexpected AChE inhibitory activity of (2E)α,β-unsaturated fatty acids.
AID1575239Stimulation of human 20S proteasome at 25 uM using 11 amino acid FRET peptide as substrate measured every 2 mins over 1 hr by FRET assay relative to control2019Bioorganic & medicinal chemistry letters, 02-01, Volume: 29, Issue:3
Analysis of chain length, substitution patterns, and unsaturation of AM-404 derivatives as 20S proteasome stimulators.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]